Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.

Yoshiko Minakuchi, Fumitaka Takeshita, Nobuyoshi Kosaka, Hideo Sasaki, Yusuke Yamamoto, Makiko Kouno, Kimi Honma, Shunji Nagahara, Koji Hanai, Akihiko Sano, Takashi Kato, Masaaki Terada, Takahiro Ochiya

Research output: Contribution to journalArticle

291 Citations (Scopus)

Abstract

Silencing gene expression by siRNAs is rapidly becoming a powerful tool for the genetic analysis of mammalian cells. However, the rapid degradation of siRNA and the limited duration of its action call for an efficient delivery technology. Accordingly, we describe here that Atelocollagen complexed with siRNA is resistant to nucleases and is efficiently transduced into cells, thereby allowing long-term gene silencing. Site-specific in vivo administration of an anti-luciferase siRNA/Atelocollagen complex reduced luciferase expression in a xenografted tumor. Furthermore, Atelocollagen-mediated transfer of siRNA in vivo showed efficient inhibition of tumor growth in an orthotopic xenograft model of a human non-seminomatous germ cell tumor. Thus, for clinical applications of siRNA, an Atelocollagen-based non-viral delivery method could be a reliable approach to achieve maximal function of siRNA in vivo.

Original languageEnglish
JournalNucleic Acids Research
Volume32
Issue number13
Publication statusPublished - 2004 Jul
Externally publishedYes

Fingerprint

Gene Silencing
Small Interfering RNA
Luciferases
Heterografts
In Vitro Techniques
atelocollagen
Neoplasms
Technology
Gene Expression
Growth

ASJC Scopus subject areas

  • Genetics

Cite this

Minakuchi, Y., Takeshita, F., Kosaka, N., Sasaki, H., Yamamoto, Y., Kouno, M., ... Ochiya, T. (2004). Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Research, 32(13).

Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. / Minakuchi, Yoshiko; Takeshita, Fumitaka; Kosaka, Nobuyoshi; Sasaki, Hideo; Yamamoto, Yusuke; Kouno, Makiko; Honma, Kimi; Nagahara, Shunji; Hanai, Koji; Sano, Akihiko; Kato, Takashi; Terada, Masaaki; Ochiya, Takahiro.

In: Nucleic Acids Research, Vol. 32, No. 13, 07.2004.

Research output: Contribution to journalArticle

Minakuchi, Y, Takeshita, F, Kosaka, N, Sasaki, H, Yamamoto, Y, Kouno, M, Honma, K, Nagahara, S, Hanai, K, Sano, A, Kato, T, Terada, M & Ochiya, T 2004, 'Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.', Nucleic Acids Research, vol. 32, no. 13.
Minakuchi Y, Takeshita F, Kosaka N, Sasaki H, Yamamoto Y, Kouno M et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Research. 2004 Jul;32(13).
Minakuchi, Yoshiko ; Takeshita, Fumitaka ; Kosaka, Nobuyoshi ; Sasaki, Hideo ; Yamamoto, Yusuke ; Kouno, Makiko ; Honma, Kimi ; Nagahara, Shunji ; Hanai, Koji ; Sano, Akihiko ; Kato, Takashi ; Terada, Masaaki ; Ochiya, Takahiro. / Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. In: Nucleic Acids Research. 2004 ; Vol. 32, No. 13.
@article{395fe40734304b20a1f4fec390cd9f57,
title = "Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.",
abstract = "Silencing gene expression by siRNAs is rapidly becoming a powerful tool for the genetic analysis of mammalian cells. However, the rapid degradation of siRNA and the limited duration of its action call for an efficient delivery technology. Accordingly, we describe here that Atelocollagen complexed with siRNA is resistant to nucleases and is efficiently transduced into cells, thereby allowing long-term gene silencing. Site-specific in vivo administration of an anti-luciferase siRNA/Atelocollagen complex reduced luciferase expression in a xenografted tumor. Furthermore, Atelocollagen-mediated transfer of siRNA in vivo showed efficient inhibition of tumor growth in an orthotopic xenograft model of a human non-seminomatous germ cell tumor. Thus, for clinical applications of siRNA, an Atelocollagen-based non-viral delivery method could be a reliable approach to achieve maximal function of siRNA in vivo.",
author = "Yoshiko Minakuchi and Fumitaka Takeshita and Nobuyoshi Kosaka and Hideo Sasaki and Yusuke Yamamoto and Makiko Kouno and Kimi Honma and Shunji Nagahara and Koji Hanai and Akihiko Sano and Takashi Kato and Masaaki Terada and Takahiro Ochiya",
year = "2004",
month = "7",
language = "English",
volume = "32",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.

AU - Minakuchi, Yoshiko

AU - Takeshita, Fumitaka

AU - Kosaka, Nobuyoshi

AU - Sasaki, Hideo

AU - Yamamoto, Yusuke

AU - Kouno, Makiko

AU - Honma, Kimi

AU - Nagahara, Shunji

AU - Hanai, Koji

AU - Sano, Akihiko

AU - Kato, Takashi

AU - Terada, Masaaki

AU - Ochiya, Takahiro

PY - 2004/7

Y1 - 2004/7

N2 - Silencing gene expression by siRNAs is rapidly becoming a powerful tool for the genetic analysis of mammalian cells. However, the rapid degradation of siRNA and the limited duration of its action call for an efficient delivery technology. Accordingly, we describe here that Atelocollagen complexed with siRNA is resistant to nucleases and is efficiently transduced into cells, thereby allowing long-term gene silencing. Site-specific in vivo administration of an anti-luciferase siRNA/Atelocollagen complex reduced luciferase expression in a xenografted tumor. Furthermore, Atelocollagen-mediated transfer of siRNA in vivo showed efficient inhibition of tumor growth in an orthotopic xenograft model of a human non-seminomatous germ cell tumor. Thus, for clinical applications of siRNA, an Atelocollagen-based non-viral delivery method could be a reliable approach to achieve maximal function of siRNA in vivo.

AB - Silencing gene expression by siRNAs is rapidly becoming a powerful tool for the genetic analysis of mammalian cells. However, the rapid degradation of siRNA and the limited duration of its action call for an efficient delivery technology. Accordingly, we describe here that Atelocollagen complexed with siRNA is resistant to nucleases and is efficiently transduced into cells, thereby allowing long-term gene silencing. Site-specific in vivo administration of an anti-luciferase siRNA/Atelocollagen complex reduced luciferase expression in a xenografted tumor. Furthermore, Atelocollagen-mediated transfer of siRNA in vivo showed efficient inhibition of tumor growth in an orthotopic xenograft model of a human non-seminomatous germ cell tumor. Thus, for clinical applications of siRNA, an Atelocollagen-based non-viral delivery method could be a reliable approach to achieve maximal function of siRNA in vivo.

UR - http://www.scopus.com/inward/record.url?scp=3242733298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242733298&partnerID=8YFLogxK

M3 - Article

C2 - 15272050

AN - SCOPUS:3242733298

VL - 32

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 13

ER -